These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

521 related items for PubMed ID: 6150740

  • 1. Selectivity and potency of 2-alkyl analogues of the alpha 2-adrenoceptor antagonist idazoxan (RX 781094) in peripheral systems.
    Doxey JC, Roach AG, Strachan DA, Virdee NK.
    Br J Pharmacol; 1984 Nov; 83(3):713-22. PubMed ID: 6150740
    [Abstract] [Full Text] [Related]

  • 2. Studies on RX 781094: a selective, potent and specific antagonist of alpha 2-adrenoceptors.
    Doxey JC, Roach AG, Smith CF.
    Br J Pharmacol; 1983 Mar; 78(3):489-505. PubMed ID: 6132640
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the alpha-adrenoceptor antagonist profiles of idazoxan (RX 781094), yohimbine, rauwolscine and corynanthine.
    Doxey JC, Lane AC, Roach AG, Virdee NK.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Feb; 325(2):136-44. PubMed ID: 6144048
    [Abstract] [Full Text] [Related]

  • 4. 2-Alkyl analogue of idazoxan (RX 781094) with enhanced antagonist potency and selectivity at central alpha 2-adrenoceptors in the rat.
    Gadie B, Lane AC, McCarthy PS, Tulloch IF, Walter DS.
    Br J Pharmacol; 1984 Nov; 83(3):707-12. PubMed ID: 6150739
    [Abstract] [Full Text] [Related]

  • 5. Differential blocking actions of idazoxan against the inhibitory effects of 6-fluoronoradrenaline and clonidine in the rat vas deferens.
    Hicks PE, Langer SZ, Macrae AD.
    Br J Pharmacol; 1985 Sep; 86(1):141-50. PubMed ID: 2864967
    [Abstract] [Full Text] [Related]

  • 6. Different sites of action for alpha 2-adrenoceptor antagonists in the modulation of noradrenaline release and contraction response in the vas deferens of the rat.
    Harsing LG, Vizi ES.
    J Pharm Pharmacol; 1992 Mar; 44(3):231-4. PubMed ID: 1354730
    [Abstract] [Full Text] [Related]

  • 7. Effects of desipramine on stimulation-induced contractions of the vas deferens of rats pretreated either chronically with desipramine or acutely with idazoxan.
    Doxey JC, Roach AG, Samuel J.
    Clin Sci (Lond); 1985 Mar; 68 Suppl 10():155s-159s. PubMed ID: 2857613
    [Abstract] [Full Text] [Related]

  • 8. Possible involvement of presynaptic alpha 1-adrenoceptors in the effects of idazoxan and prazosin on 3H-noradrenaline release from tail arteries of SHR.
    Hicks PE, Najar M, Vidal M, Langer SZ.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):354-61. PubMed ID: 2877400
    [Abstract] [Full Text] [Related]

  • 9. Selectivity profile of the alpha 2-adrenoceptor antagonist efaroxan in relation to plasma glucose and insulin levels in the rat.
    Berridge TL, Doxey JC, Roach AG, Smith CF.
    Eur J Pharmacol; 1992 Mar 24; 213(2):205-12. PubMed ID: 1355733
    [Abstract] [Full Text] [Related]

  • 10. A study of the selectivity and potency of rauwolscine, RX 781094 and RS 21361 as antagonists of alpha-1 and alpha-2 adrenoceptors.
    Timmermans PB, Qian JQ, Ruffolo RR, van Zwieten PA.
    J Pharmacol Exp Ther; 1984 Mar 24; 228(3):739-48. PubMed ID: 6142941
    [Abstract] [Full Text] [Related]

  • 11. Some pharmacological properties of Wy 27127 a more selective alpha 2:alpha 1-adrenoceptor antagonist than idazoxan in vitro.
    Bill SJ, Boniface A, Haroun F, McAdams RP, Lattimer N, Rhodes KF.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec 24; 334(4):418-22. PubMed ID: 2881217
    [Abstract] [Full Text] [Related]

  • 12. The alpha adrenoceptor antagonist properties of idazoxan in normal subjects.
    Elliott HL, Jones CR, Vincent J, Lawrie CB, Reid JL.
    Clin Pharmacol Ther; 1984 Aug 24; 36(2):190-6. PubMed ID: 6146423
    [Abstract] [Full Text] [Related]

  • 13. Alpha-adrenoceptor antagonism by apoyohimbine and some observations on the pharmacology of alpha-adrenoceptors in the rat anococcygeus and vas deferens.
    McGrath JC.
    Br J Pharmacol; 1984 Aug 24; 82(4):769-81. PubMed ID: 6148114
    [Abstract] [Full Text] [Related]

  • 14. Electrophysiological demonstration of both alpha 2-agonist and antagonist properties of RX 781094.
    Goldstein JM, Knobloch LC, Malick JB.
    Eur J Pharmacol; 1983 Jul 15; 91(1):101-5. PubMed ID: 6137390
    [Abstract] [Full Text] [Related]

  • 15. Studies of alpha 2-adrenoceptor antagonist potency in vitro: comparisons in tissues from rats, rabbits, dogs and humans.
    Waterfall JF, Rhodes KF, Lattimer N.
    Clin Sci (Lond); 1985 Jul 15; 68 Suppl 10():21s-24s. PubMed ID: 2857614
    [Abstract] [Full Text] [Related]

  • 16. Highly selective and specific antagonism of central and peripheral alpha 2-adrenoceptors by atipamezole.
    Virtanen R, Savola JM, Saano V.
    Arch Int Pharmacodyn Ther; 1989 Jul 15; 297():190-204. PubMed ID: 2567152
    [Abstract] [Full Text] [Related]

  • 17. Napamezole, an alpha-2 adrenergic receptor antagonist and monoamine uptake inhibitor in vitro.
    Perrone MH, Hamel LT, Ferrari RA, Haubrich DR.
    J Pharmacol Exp Ther; 1990 Aug 15; 254(2):471-5. PubMed ID: 1974637
    [Abstract] [Full Text] [Related]

  • 18. Cardiac alpha-adrenoceptors: postjunctional and prejunctional.
    Rand MJ, Tung LH, Louis WJ, Story DF.
    J Mol Cell Cardiol; 1986 Nov 15; 18 Suppl 5():17-32. PubMed ID: 2433457
    [Abstract] [Full Text] [Related]

  • 19. Heterogeneity of smooth muscle alpha adrenoceptors in rat tail artery in vitro.
    Medgett IC, Langer SZ.
    J Pharmacol Exp Ther; 1984 Jun 15; 229(3):823-30. PubMed ID: 6144792
    [Abstract] [Full Text] [Related]

  • 20. Alpha 2-adrenoceptor antagonism and other pharmacological antagonist properties of some substituted benzoquinolizines and yohimbine in vitro.
    Lattimer N, McAdams RP, Rhodes KF, Sharma S, Turner SJ, Waterfall JF.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Oct 15; 327(4):312-8. PubMed ID: 6151116
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.